The Maillard reaction in food: A concern for human health?;La réaction de Maillard dans les aliments: Quels enjeux pour la santé humaine?

Cahiers de Nutrition et de Dietetique

Volumn 43, Issue 6, 2008, Pages 289-295

  Birlouez Aragon, Inès ^a,b  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b BIOCITECH   (France)

Author keywords

Food; Health; Heat treatment; Maillard reaction; Neoformed contaminants

Indexed keywords

ADVANCED GLYCATION END PRODUCT; GLUCOSE; LIPID;

CARCINOGENICITY; CHEMICAL REACTION; CYTOKINE RELEASE; DIETARY INTAKE; FOOD ANALYSIS; FOOD CONTAMINATION; FOOD QUALITY; FOOD SAFETY; GLYCATION; HEAT TREATMENT; HUMAN; PROTEIN INTAKE; REACTION ANALYSIS; REVIEW; RISK ASSESSMENT;

EID: 60349101385     PISSN: 00079960     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0007-9960(08)75570-6     Document Type: Article

References (34)

1. Maillard L.C. - Action des acides aminés sur les sucres : formation des mélanoïdines par voie méthodique. Compte-rendu de l'Académie des sciences, 1912, 154, 66-68.
2. Fuganti C., Gatti F.G., Serra S. - A general method for the synthesis of the most powerful naturally occurring Maillard flavors. Tetrahedron, 2007, 63, 4762-4767.
3. Thorpe S.R., Baynes J.W. - Role of the Maillard reaction in diabetes and diseases of aging Drugs & ageing, 1996, 9, 69-77.
4. Slayne M.A., Linebak D.R. - Acrylamide: considerations for risk management. J. AOAC Int., 2005, 88, 227-233.
5. Kochinsky T., He C.J., Mitsuhashi T. et al. - Orally absorbed reactive glycation products : an environmental risk factor for diabetic nephropathy. Proc. Natl. Acad. Sci., 1997, 94, 6474-6479.
6. Cheng K.-W., Feng C., Mingfu W. - Heterocyclic amines: Chemistry and health. Mol. Nutr. Food Res., 2006, 50, 1150-1170.
7. Jun H.-J., Lee K.-G., Woo G.-J., Young S.P., Lee S.-J. - Correlation of urinary furan with plasma γ-glutamyl-transpeptidase levels in healthy men and women. Food Chem. Toxicol. 2008, 46, 1753-1759.
8. Hodge J.E. - Chemistry of browning reactions in model systems. J. Agric. Food Chem., 1953, 1, 928-943.
9. Letzeltzer N., Birlouez-Aragon I. - La réaction de Maillard et le vieillissement. Cah. Nutr. Diét., 1992, 27, 18-23.
10. Thornalley P.J., Langborg A., Minhas H.S. - Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose. Biochem. J., 1999, 344, 109-116.
11. Fu M.-X., Requena J.R., Jenkins A.J. et al. - The Advanced Glycation End Product, N-(Carboxymethyl)lysine, Is a Product of both Lipid Peroxidation and Glycoxidation Reactions. J. Biol. Chem., 1996, 271, 9982-9986.
12. Zoccali C., Mallamaci F., Tripepi G. - AGEs and carbonyl stress: potential pathogenetic factors of long-term uraemic complications. Nephrol. Dial Transplant., 2000, 15, 7-11.
13. CIARC. - Évaluation du risque de cancer chez l'homme. 2006, 63, 3194-3107.
14. Charissou A., Ait-Ameur L., Birlouez-Aragon I. - Evaluation of a gas chromatography/mass spectrometry method for the quantification of carboxymethyllysine in food samples. J. Chromatogr. A, 2007, 1140, 189-194.
15. Knecht K.J., Dunn J.A., Mcfarland K.F. et al. - Effect of diabetes and aging on carboxymethyllysine levels in human urine. Diabetes, 1991, 40, 190-196.
16. ε- (Carboxymethyl) Lysine Adducts of Proteins Are Ligands for Receptor Cell Signaling Pathways and Modulate Gene Expression. J. Biol. Chem., 1999, 274, 31740-31749.
17. Tessier F., Birlouez-Aragon I. - Effect of pH, phosphate and copper concentration on advanced Maillard reaction. Glycoconj. J., 1997, 15, 571-574.
18. Birlouez-Aragon I., Pischetsrieder M., Leclere J. et al. - Loss of nutritional quality and chemical safety in heat-processed infant formulas. Food Chem., 2004, 87, 253-259.
19. Vlassara H., Cai W., Crandall J. et al. - Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy. PNAS, 2002, 99, 15596-15601.
20. Erbersdobler H.F., Faist V. - Metabolic transit of Amadori products. Nahrung/Food, 2001, 45, 177-181.
21. Somoza V., Wenzel E., Weiß C. et al. - Dose dependent utilisation of casein-linked lysinoalanine, N-epsilon-fructoselysine and N-epsilon-carboxymethyllysine in rats. Mol. Nutr. Food Res., 2006, 50, 833-841.
22. Sebekova K., Saavedra G., Zumpe C., Somoza V., Klenovicsova K. Birlouez-Aragon I. - Plasma concentration and urinary excretion of carboxymethyllysine in breast milk versus infant formulas fed healthy 6 months old infants. Ann. NY Acad. Sci., 2008, 1126, 177-180.
23. Uribarri J., Peppa M., Cai W. et al. - Dietary glycotoxins correlate with circulating advanced glycation end product levels in renal failure patients. Am. J. Kid. Dis., 2003, 42, 532-538.
24. Brownlee M., Cerami A., Vlassara H. - Advanced glycosylation end-products in tissue and the biochemical basis of diabetic complications. N. Engl. J. Med., 1988, 318, 1315-1321.
25. Lin R.-Y., Choudhury R., Cai W. et al. - Dietary glycotoxins promote diabetic atherosclerosis in apolipoprotein E-deficient mice. Atherosclerosis, 2003, 168, 213-220.
26. Sandu O., Cai W., Dong H.-J. et al. - Insulin resistance (IR) and type 2 diabetes (T2D) in high fat-fed mice are linked to high glycotoxin, rather than high fat intake. Diabetes, 2004, 54, 2314-2319.
27. Peppa M., He C., Hattori M. et al. - Fetal or neonatal low-glycotoxin environment prevents autoimmune diabetes in NOD mice. Diabetes, 2003, 52, 1441-1448.
28. Cijiang H., Sabol J., Mitsushahi T., Vlassara H. - Dietary glycotoxins: Inhibition of reactive products by aminoguanidine facilitates renal clearance and reduces tissue sequestration. Diabetes, 1999, 48, 1308-1315.
29. Hofmann S.M., Dong H.-J., Zhu L. et al. - Improved insulin sensitivity is associated with restricted intake of dietary glycoxidation products in the db/db mouse. Diabetes, 2002, 51, 2082-2089.
30. Negrean M., Stirban A., Stratmann B. et al. - Effects of low-and high-advanced glycation endproduct meals on macro-and microvascular endothelial function and oxidative stress in patients with type 2 diabetes mellitus. Am. J. Clin. Nutr., 2007, 85, 1236-1243.
31. Saavedra G., Ait-Ameur L., Tessier F. et al. - Les produits de Maillard issus de la cuisson des aliments ont-ils des effets biologiques ? NAFAS, 2008, 6, 59-63.
32. Pouillart P., Mauprivez H., Ait-Ameur L. et al. - Strategy for the study of health impact of dietary Maillard products in clinical studies: the example of the ICARE clinical study on healthy subjects. Ann. NY Acad. Sci., 2008, 1126, 173-176.
33. ε-carboxymethyllysine-modified proteins are unable to bind to RAGE and activate an inflammatory response. Mol. Nutr. Food Res., 2008, 52, 370-378.
34. Farmer P.B., Brown K., Tompkins E. et al. - DNA adducts: Mass spectrometry methods and future prospects. Toxicol. Appl. Pharmacol., 2005, 207, 293-301.